<amendment session="109" chamber="h" number="696" updated="2013-07-17T08:16:18-04:00">
  <amends type="h" number="2829" sequence="11"/>
  <status datetime="2006-03-09T14:02:00-05:00">pass</status>
  <sponsor id="400249"/>
  <offered datetime="2006-03-09"/>
  <description>Amendment requires the Director of the Office of National Drug Control Policy to request the Institute of Medicine of the National Academy of Sciences to conduct a study to examine certain aspects of iatrogenic addiction, which is associated with prescription drugs like OxyContin.</description>
  <purpose>An amendment numbered 11 printed in House Report 109-387 to direct the ONDCP to request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study on iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets and directs the ONDCP to report to Congress on the study.</purpose>
  <actions>
    <action datetime="2006-03-09T13:51:00-05:00">
      <text>Amendment (A011) offered by Mr. Lynch.</text>
      <reference ref="CR H834-835" label="consideration"/>
      <reference ref="CR H834" label="text"/>
    </action>
    <vote datetime="2006-03-09T14:02:00-05:00" how="by voice vote" result="pass">
      <text>On agreeing to the Lynch amendment (A011) Agreed to by voice vote.</text>
    </vote>
  </actions>
</amendment>
